Filing Details
- Accession Number:
- 0001144204-18-014761
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-14 20:23:26
- Reporting Period:
- 2018-02-22
- Accepted Time:
- 2018-03-14 20:23:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1540159 | Stellar Biotechnologies Inc. | SBOT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1621331 | E. Daniel Morse | C/O Stellar Biotechnologies, Inc. 332 East Scott Street Port Hueneme CA 93041 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares, Without Par Value | Disposition | 2018-02-22 | 7,800 | $0.78 | 28,866 | No | 4 | S | Indirect | Joint Account with Spouse |
| Common Shares, Without Par Value | Disposition | 2018-02-26 | 7,000 | $0.79 | 21,866 | No | 4 | S | Indirect | Joint Account with Spouse |
| Common Shares, Without Par Value | Disposition | 2018-02-28 | 7,000 | $0.79 | 14,866 | No | 4 | S | Indirect | Joint Account with Spouse |
| Common Shares, Without Par Value | Disposition | 2018-03-09 | 7,000 | $0.81 | 7,866 | No | 4 | S | Indirect | Joint Account with Spouse |
| Common Shares, Without Par Value | Disposition | 2018-03-12 | 3,500 | $0.80 | 4,366 | No | 4 | S | Indirect | Joint Account with Spouse |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | Joint Account with Spouse |
| No | 4 | S | Indirect | Joint Account with Spouse |
| No | 4 | S | Indirect | Joint Account with Spouse |
| No | 4 | S | Indirect | Joint Account with Spouse |
| No | 4 | S | Indirect | Joint Account with Spouse |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Share Option (Right to Buy) | Acquisiton | 2018-03-12 | 2,500 | $0.00 | 2,500 | $0.84 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,500 | 2025-03-12 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Shares, Without Par Value | 194,523 | Direct |
Footnotes
- Option grant under the 2017 Incentive Compensation Plan, which shall vest as to one-third immediately, as to one-third on March 12, 2019 and as to the remaining one-third on September 12, 2019.
Billionaire Hedge Funds
